Top Health Tools
Top Health Tools

Top Reports
Top Reports
 
Top Articles
Top Articles

Top Reviews
Top Reviews
   
 
Governments Massively Stockpiling
Vaccines For Campaigns This Fall

As the WHO and international media conglomerates continue their scare tactics regarding the H1N1 flu, governments around the world are stockpiling hundreds of millions of doses of vaccines for possible autumn vaccination campaigns.

In late April, sources close to investigative journalist Wayne Madsen reported that the outbreak of swine flu was the result of the introduction of a human-engineered pathogen capable of producing a widespread global pandemic. “A top scientist for the United Nations, who has examined the outbreak of the deadly Ebola virus in Africa, as well as HIV/AIDS victims, concluded that H1N1 possesses certain transmission ‘vectors’ that suggest that the new flu strain has been genetically-manufactured as a military biological warfare weapon,” Madsen reported.

Vaccine researcher and Naturopathic Doctor, Dave Mihalovic stated that "biological warfare always comes with the opporunity for the problem makers to transparently become the problem solvers and profit handsomely while they're at it. Big Pharma has taken the lead as the world's H1N1 swine flu problem solvers by commiting to manufacture and sell billions of dollars of drugs and vaccines."

One of the largest pharmaceutical companies in the world, GlaxoSmithKline, is now preparing to sell £3bn worth of swine flu drugs this year. It revealed its vaccine, one of the world's first, could be available by September after the UK government placed advance orders for 60m doses after only 31 supposed deaths in Britain from the swine flu.

It also disclosed that international governments were stockpiling large supplies of GSK's anti-viral treatment Relenza, which can relieve swine flu symptoms.

Worldwide sales from the two drugs are expected to reach £3bn by January, but the company rejected claims it was exploiting the pandemic – stressing that profits would be much lower once development costs were taken into account.

In a sign of how quickly GSK is working to make sure a vaccine is available for the fall, the company said that "clinical trials will be limited, due to the need to provide the vaccine to governments as quickly as possible.

The Dangers of Adjuvants

GlaxoSmithKline also makes Prepandrix, a vaccine for the bird flu listed as a biodefense stockpile. The index lists a very dangerous adjuvant called squalene as one of the vaccine ingredients. When a virus is injected into your body in a vaccine, and especially when combined with an immune adjuvant like squalene, your immune system is bypassed and your body’s immune system kicks into high gear in response to the vaccination. Adjuvants cause your immune system to overreact to the introduction of the organism you’re being vaccinated against.

Gulf War veterans with Gulf War Syndrome (GWS) received anthrax vaccines which contained squalene (the Novartis squalene adjuvant) and has since been linked to the devastating autoimmune diseases suffered by countless Gulf War vets.

Micropaleontologist Dr. Viera Scheibner, who conducted research into the adverse effects of adjuvants in vaccines, wrote the following about squalene.

Squalene “contributed to the cascade of reactions called “Gulf War syndrome. (GIs developed) arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, ALS, Raynaud’s phenomenon, Sjorgren’s syndrome, chronic diarrhea, night sweats and low-grade fever.

At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines. Why? Adjuvants are supposed to get the job done faster (but certainly not more safely), which reduces the amount of vaccine required per dose, and the number of doses given per individual. Less vaccine required per person means more individual doses available for mass vaccination campaigns. Coincidentally, this is exactly the goal of government and the pharmaceutical companies who stand to make millions from their vaccines.

Legal Immunity For Swine Flu Vaccine Makers

The Obama Administration has signed a document of immunity from legal prosecution. The FDA in the United States and UK health authorities have decided to let Big Pharma put vaccine products onto the market before any tests of the possible harmful side effects of the vaccines are even known.

The first doses of swine flu vaccine will be given to the public before full data on its safety and effectiveness become available. The untested “pandemic” vaccines will be spread over two doses in a higher quantity, and one brand reportedly will contain a chemical additive, an adjuvant, to make it “go further,” dramatically potentially increasing the risk of side-effects.

Children will be among those first in line for the shots and may get the vaccine more than a month before trial results are received.

In the UK the government’s National Health Service, NHS, has been ordered to plan for a worst-case scenario in which swine flu might cause 65,000 deaths over the coming winter, including several thousand deaths among children.

Curiously enough, a full year before any reported case of the current alleged H1N1, the major pharmaceutical company, Baxter International, filed for a patent for H1N1 vaccine.

Baxter International was recently caught in a scandal after it emerged they had sent out vaccines contaminated with the H5N1 avian flu virus to 18 countries from their Austrian branch.

"Baxter is clearly applying the good old problem-reaction-solution scenario to use human beings as guinea pigs and reap the profits." said ' Mihalovic.

Baxter Vaccine Patent Application US 2009/0060950 A1. Their application states, “the composition or vaccine comprises more than one antigen.....such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes."

The application further states, “Suitable adjuvants can be selected from mineral gels, aluminium hydroxide, surface active substances, lysolecithin, pluronic polyols, polyanions or oil emulsions such as water in oil or oil in water, or a combination thereof. Of course the selection of the adjuvant depends on the intended use. E.g. toxicity may depend on the destined subject organism and can vary from no toxicity to high toxicity."

With no legal liability, could it be that Baxter is preparing to sell hundreds of millions of doses containing highly toxic aluminium hydroxide as adjuvant? Perhaps it is time to demand that all leading officials first take the vaccine before it is given to the public. This includes the WHO, CDC and the entire U.S. Obama Administration. The same should apply as well for other national health bodies demanding its citizens take the H1N1 vaccine from GlaxoSmithKline or Baxter to see if it is really safe.

600 Million Doses

A report last week from JPMorgan, the investment bank, estimated that governments had ordered nearly 600m doses of pandemic vaccine and adjuvant – a chemical that boosts its efficacy – worth $4.3bn (€3bn, £2.6bn) in sales, and there was potential for 342m more doses worth $2.6bn.

It forecast that fresh antiviral sales could boost sales for GSK and Roche by another $1.8bn.

World Health Organization and U.S. health officials have said they want to start vaccinating people against H1N1, alongside regular seasonal flu, in October.

Five companies are making H1N1 vaccine for the U.S. market -- AstraZeneca's MedImmune unit, Australia's CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.

Novartis recently announced that they would not give free vaccines to impoverished nations—everybody pays.

Baxter International has orders for 80 million H1N1 swine flu vaccines from UK, Ireland, and New Zealand.

Scare Tactics In Full Force

The fear mongering is a never ending journey when it comes to controlling the masses. The mainstream media is in full force ensuring the public be kept in a state of fear by spewing countless reports on the potential for the deadly swine flu to spread to millions.

Alan Johnson, Home Secretary of Britain said the swine flu is a greater threat to Britain than terrorism as noted in the Telegraph.

The fact that one of the UK government’s top advisors on swine flu also happens to be a sitting board member of GlaxoSmithKline is quite the conflict of interest.

“Professor Sir Roy Anderson sits on the Scientific Advisory Group for Emergencies (Sage), a 20-strong task force drawing up the action plan for the virus. Yet he also holds a £116,000-a-year post on the board of GlaxoSmithKline,” reports the Daily Mail.

Anderson was “one of the first UK experts to call the outbreak a pandemic,” and has been busy on radio and TV pushing the effectiveness of anti-virals to fight swine flu, without telling listeners that he was on the GSK payroll.

Anderson was also a key government advisor during the 2001 foot and mouth outbreak in Britain which led to the slaughter of over 6 million animals and the complete decimation of the farming industry.

As reported in the Associated Press, U.S. health officials said that the swine flu could strike up to 40 percent of Americans over the next two years and as many as several hundred thousand could die if a vaccine campaign and other measures aren't successful.

There are even reports from New Scientist that claim that overweight people appear more likely to die of swine flu. "Considering that almost 70 percent of the U.S. is overweight, that can have a phenomal psychological impact on the state of fear for the majority of Americans." states Mihalovic.

Another indication that the world is being taken for colossal suckers in the entire WHO Swine Flu scare scenario, the WHO itself, the world body entrusted to monitor outbreaks of so-called pandemics or even epidemics worldwide, has just decided to stop tracking Swine Flu or H1N1 Influenza A as they prefer to name it now.

The World Health Organization in a “briefing note” on their Web site posted the baffling notice that they would no longer track outbreaks of H1N1. The last WHO update, issued July 6, showed 94,512 confirmed cases in 122 countries, with 429 deaths. The WHO apparently claims that the numbers of laboratory-confirmed cases were actually meaningless.

They have decided to drop tests that did not give a scientific picture of who had H1N1 or not, and as well they have decided to drop counting any test results or cases of H1N1 around the world with the comment that “we can assume almost all cases are H1N1 Swine Flu." This is the junk science that the WHO uses to decisively declare who is infected with H1N1. Any questions?

Journalist Wayne Madsen talks about the
Manufactured H1N1 Virus with Russia Today.


Share/Bookmark
...............................................................................................................

This site is owned and operated by PreventDisease.com 1999-2014. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
aaa
Interact
volunteerDonateWrite For Us
Stay Connected With Our Newsletter